The battle over the merits of an anti-malarial drug as a potential treatment for coronavirus is raging within the White House, as health experts caution against President Trump's frequent touting of hydroxychloroquine.
White House trade adviser Peter Navarro on Monday appeared to confirm reports of a heated meeting over the ...
from www.washingtontimes.com stories: Health https://ift.tt/2RxbkFF